These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2560598)
1. Acetylator phenotype and short-course chemotherapy for tuberculosis in Papua New Guinea. Currie B; Krause V; Mondia P; Hudson B P N G Med J; 1989 Dec; 32(4):259-62. PubMed ID: 2560598 [TBL] [Abstract][Full Text] [Related]
2. Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. Nisar M; Watkin SW; Bucknall RC; Agnew RA Thorax; 1990 May; 45(5):419-20. PubMed ID: 2166360 [TBL] [Abstract][Full Text] [Related]
3. Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit. Hein DW; Weber WW J Pharmacol Exp Ther; 1984 Mar; 228(3):588-92. PubMed ID: 6707910 [TBL] [Abstract][Full Text] [Related]
4. Pyridoxine supplementation during isoniazid therapy. Snider DE Tubercle; 1980 Dec; 61(4):191-6. PubMed ID: 6269259 [TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy secondary to isoniazid-induced pyridoxine deficiency. Aita JF; Calame TR Md State Med J; 1972 Oct; 21(10):68-70. PubMed ID: 4353461 [No Abstract] [Full Text] [Related]
6. Acetylator phenotypes in Papua New Guinea. Penketh RJ; Gibney SF; Nurse GT; Hopkinson DA J Med Genet; 1983 Feb; 20(1):37-40. PubMed ID: 6842533 [TBL] [Abstract][Full Text] [Related]
10. An assessment of acetylator polymorphism and its relevance in Papua New Guinea. Hombhanje F P N G Med J; 1990 Jun; 33(2):107-10. PubMed ID: 2238823 [TBL] [Abstract][Full Text] [Related]
11. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis. Singh SP; Pande JN; Khilnani GC; Kailash S Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742 [TBL] [Abstract][Full Text] [Related]
12. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases]. Bouayad Z; Chevalier B; Maurin R; Bartal M Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595 [TBL] [Abstract][Full Text] [Related]
13. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid. Ylitalo P; Auterinen L; Marttinen A; Koivula T Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440 [TBL] [Abstract][Full Text] [Related]
14. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Ena J; Valls V Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411 [TBL] [Abstract][Full Text] [Related]
15. Acetylator status, drug metabolism and disease. Pande JN; Pande A; Singh SP Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953 [TBL] [Abstract][Full Text] [Related]
16. Isoniazid induced motor-dominant neuropathy. Arsalan R; Sabzwari S J Pak Med Assoc; 2015 Oct; 65(10):1131-3. PubMed ID: 26440850 [TBL] [Abstract][Full Text] [Related]
17. Pyridoxine supplementation with isonex: is it necessary? Maheshwari RK; Gupta BD Indian Pediatr; 1991 Sep; 28(9):1085-7; author reply 1087-8. PubMed ID: 1802853 [No Abstract] [Full Text] [Related]
18. [Adjusting or not adjusting isoniazid dosage?]. Parrot R; Boval C; Grosset J; Gaillard JP Rev Fr Mal Respir; 1983; 11(5):705-12. PubMed ID: 6658156 [TBL] [Abstract][Full Text] [Related]
19. The management of asthma in children in Papua New Guinea. Vince JD P N G Med J; 1996 Dec; 39(4):329-37. PubMed ID: 10214092 [TBL] [Abstract][Full Text] [Related]
20. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute. Augustynowicz-Kopeć E; Zwolska Z Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]